Clinical Trial Update: Motivation and Patch Treatment for HIV-positive Smokers [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on a nicotine patch treatment for HIV-positive smokers, outlining the trial motivation and that the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tobacco Use Disorder

Drugs mentioned

• Nicotine transdermal patch (nicotine patch)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: HIV Infections, Smoking Cessation | Phase 3 | Status: COMPLETED